Malignant neoplasm of larynx
Chapter 2:Neoplasms
ICD-10 C32 is a billable code used to indicate a diagnosis of malignant neoplasm of larynx.
Malignant neoplasm of the larynx, commonly referred to as laryngeal cancer, arises from the epithelial cells lining the larynx. This type of cancer is often associated with risk factors such as tobacco use, excessive alcohol consumption, and exposure to certain chemicals. Symptoms may include hoarseness, difficulty swallowing, persistent cough, and throat pain. Diagnosis typically involves laryngoscopy, imaging studies, and biopsy. Staging of laryngeal cancer is crucial for determining treatment options and prognosis, with stages ranging from localized tumors (Stage I) to advanced disease with regional or distant metastasis (Stage IV). Treatment may involve surgery, radiation therapy, and chemotherapy, with a focus on voice preservation techniques, especially in early-stage cases. The management of laryngeal cancer requires a multidisciplinary approach, including oncologists, surgeons, and speech therapists, to optimize outcomes and maintain quality of life.
Detailed notes on laryngeal examination findings, imaging results, and treatment plans.
Diagnosis and management of laryngeal cancer, including preoperative assessments and postoperative follow-ups.
Ensure accurate staging and documentation of voice preservation techniques.
Comprehensive treatment plans, including chemotherapy regimens and radiation therapy details.
Management of advanced laryngeal cancer and coordination of multidisciplinary care.
Document patient discussions regarding treatment options and potential side effects.
Performed for advanced laryngeal cancer requiring removal of the larynx.
Operative report detailing the procedure and any complications.
Otolaryngology specialists must document the rationale for surgery.
Common symptoms include persistent hoarseness, difficulty swallowing, a lump in the neck, and chronic cough. Early detection is crucial for effective treatment.
